INOVIQ says it has found a way to test blood for Parkinson’s Disease – after Alzheimer’s success in June

The Market Herald08-20

If you’re looking for a reason why INOVIQ (ASX:IIQ) shares jumped 6% out the gate on Tuesday, it’s this – after announcing similar success for Alzheimer’s patients in June, the company now says it can...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2460161900?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-20 08:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2460161900","market":"hk","top_or_hot":-1,"title":"INOVIQ says it has found a way to test blood for Parkinson’s Disease – after Alzheimer’s success in June","media":"The Market Herald","content":"<div>\n<p>If you’re looking for a reason why INOVIQ (ASX:IIQ) shares jumped 6% out the gate on Tuesday, it’s this – after announcing similar success for Alzheimer’s patients in June, the company now says it can...</p>\n\n<a href=\"https://themarketonline.com.au/inoviq-says-it-has-found-a-way-to-test-blood-for-parkinsons-disease-after-alzheimers-success-in-june-2024-08-20/\">Source Link</a>\n\n</div>\n","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INOVIQ says it has found a way to test blood for Parkinson’s Disease – after Alzheimer’s success in June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINOVIQ says it has found a way to test blood for Parkinson’s Disease – after Alzheimer’s success in June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-20 08:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketonline.com.au/inoviq-says-it-has-found-a-way-to-test-blood-for-parkinsons-disease-after-alzheimers-success-in-june-2024-08-20/><strong>The Market Herald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you’re looking for a reason why INOVIQ (ASX:IIQ) shares jumped 6% out the gate on Tuesday, it’s this – after announcing similar success for Alzheimer’s patients in June, the company now says it can...</p>\n\n<a href=\"https://themarketonline.com.au/inoviq-says-it-has-found-a-way-to-test-blood-for-parkinsons-disease-after-alzheimers-success-in-june-2024-08-20/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IIQ.AU","symbol_name":"INOVIQ LTD","start_time":0,"source_url":"https://themarketonline.com.au/inoviq-says-it-has-found-a-way-to-test-blood-for-parkinsons-disease-after-alzheimers-success-in-june-2024-08-20/","article_id":"2460161900","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2460161900","pubTimestamp":1724115540,"columns":[],"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"If you’re looking for a reason why INOVIQ  shares jumped 6% out the gate on Tuesday, it’s this – after announcing similar success for Alzheimer’s patients in June, the company now says it can test blood for Parkinson’s.it all boils down to Inoviq’s software-based proprietary platform, ‘NEURO-NET,’ which ultimately creates a computerised “protein fingerprint” from blood sample data that can differentiate between donors with “normal healthy blood” and those with target conditions.Both Alzheimer’s Disease , and now Parkinson’s Disease , are target conditions INOVIQ states NEURO-NET is more than able to identify.The implications are obvious: INOVIQ may have just cracked the code to diagnosing Parkinson’s before the condition has a chance to begin reducing quality of life – or before patients let any more time pass.“NEURO-NET enriches known protein biomarkers of neurodegenerative diseases by 5-8-fold compared to measuring them directly from blood, greatly increasing the potential for earlie","collect":0,"end_time":0,"defaultTopTitle":"themarketonline.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"IIQ.AU":"INOVIQ LTD","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","PD":"PagerDuty, Inc.","BK7124":"保健护理服务","BK4023":"应用软件"},"translate_title":"INOVIQ表示，继六月份阿尔茨海默病取得成功后，它已经找到了一种检测血液中帕金森病的方法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IIQ.AU":1,"PD":1},"content_text":"If you’re looking for a reason why INOVIQ (ASX:IIQ) shares jumped 6% out the gate on Tuesday, it’s this – after announcing similar success for Alzheimer’s patients in June, the company now says it can test blood for Parkinson’s.\nit all boils down to Inoviq’s software-based proprietary platform, ‘NEURO-NET,’ which ultimately creates a computerised “protein fingerprint” from blood sample data that can differentiate between donors with “normal healthy blood” and those with target conditions.\nBoth Alzheimer’s Disease (AD), and now Parkinson’s Disease (PD), are target conditions INOVIQ states NEURO-NET is more than able to identify.\nThe implications are obvious: INOVIQ may have just cracked the code to diagnosing Parkinson’s before the condition has a chance to begin reducing quality of life – or before patients let any more time pass.\n“NEURO-NET enriches known protein biomarkers of neurodegenerative diseases by 5-8-fold compared to measuring them directly from blood, greatly increasing the potential for earlier detection of the onset of Parkinson’s disease,” INOVIQ wrote on Tuesday.\nManagement further elaborated.\n“NEURO-NET has now been validated to capture brain-derived exosomes and identify blood-based exosomal protein biomarkers in both AD and PD,” INOVIQ CEPO Leearne Hinch said.\n“These biomarkers can be used to develop potential exosome-based blood tests for earlier detection and/or treatment selection of AD and PD.”\nThe company is now looking at the university sector to find an academic partner with which to further test the tech and bolster results – towards, eventually, a potential commercialisation of the product down the line.\nIIQ last traded at 59cps.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460161900"}